actinobac biomed Inc. logo

Actinobac Biomed, Inc.

Actinobac is a biopharmaceutical company developing therapeutics for multiple indications, including blood cancers, autoimmune/inflammatory diseases, and HIV. Our drug candidates are based upon Leukothera® (LtxA), a natural protein that targets and eliminates white blood cells (WBCs) involved in the mechanism of many diseases. Products based upon Leukothera® are being developed by Actinobac for the treatment of leukemia/lymphoma, dry eye, and psoriasis.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.actinobac.com
Disease Focus
Development Stage
STOCK CODENon Listed
Address
15 Pelham Road Kendall Park,08824
New Jersey
United States
Email
Contact Number
+1 732-371-2694

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/actinobac-biomed-inc.” connections=”true” suffix=””]